Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
Date:7/23/2008

DETROIT, July 23 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (Amex: CPD) announced the resignation as a Director of the Company of Jitendra N. Doshi and the appointment as a Director of the Company of Gurpartap ("GP") Singh Sachdeva, the Senior Vice President - Business Strategies of the Company, effective July 22, 2008.

Prior to his appointment as Senior Vice President of Business Strategies in July 2007, Mr. Singh served as Vice President - Sales and Marketing (September 2003 to July 2007) and National Sales and Marketing Manager (September 2000 to September 2003) of the Company. From May 1998 to September 2000, Mr. Singh was the Manager of Bulk Drugs for Sun Pharmaceutical Industries Limited.

Daniel H. Movens, the Company's Chief Executive Officer, noted that Dr. Doshi had an extensive history of dedicated service to the Company stating that "Mr. Doshi has provided invaluable service to the Company as an executive officer, including CEO, and as a Director, since 2001. His efforts greatly contributed to the success we have achieved." Mr. Doshi continues to serve as an Executive Director for Sun Pharmaceutical Industries Inc.

Mr. Movens continued, "We are very pleased to welcome Mr. Singh to the Board. His experience, depth of knowledge and accomplished background should provide us with good guidance into the foreseeable future. We are certain that he will bring to the Board the same energy and sound judgment that he has shown as an executive officer of the Company."

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expecta
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
2. Sonus Pharmaceuticals Receives Favorable NASDAQ Decision
3. Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
4. Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering
5. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
6. Worlds Top 20 Pharmaceutical Companies Deploy Revolutionary H-Cube(R) From ThalesNano Inc.
7. Amylin Pharmaceuticals to Webcast Second Quarter Results
8. Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
9. ViroPharma To Acquire Lev Pharmaceuticals
10. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
11. Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...RNewswire-FirstCall/ -- Peregrine Pharmaceuticals,...f patient enrollment in a dose confirmation and do...apsed glioblastoma multiforme (GBM), the deadliest...lonal antibody linked to a radioisotope being deve...a specifically targets cells at the center of brai...
(Date:12/2/2009)...ds, December 2 Pepscan Holding NV,...ing on protein mimicking,technology for the genera...t,has appointed Wim E.M. Mol, Ph.D. as new Chief E...nsible for all of Pepscans corporate functions and... the company. He brings to,Pepscan more than 20 ye...
(Date:12/2/2009)...ewswire/ -- S*BIO Pte Ltd today announced data pre...8, at The American Society of Hematology 51st Annu...ta will be presented on the clinical results from ...ing its safety, tolerability and pharmacokinetic/p...ing from 100 to 600 mg. These doses were administe...
(Date:12/2/2009)...ire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: A...aceutical company focused on endocrine therapy and...Drug Administration (FDA) has granted Fast Track d...bitor compound, perifosine (KRX-0401), for the tre...ryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...annKind,Corporation (Nasdaq: MNKD ) will release ..., May 5, 2008 at 4:00 p.m. EDT., Management of th...he,first quarter financial results, clinical progr...T on Monday, May 5, 2008. Presenting from the,Comp...er, Alfred Mann;,President and Chief Operating Off...
...angamo,BioSciences, Inc. (Nasdaq: SGMO ), a leade...nger DNA-binding proteins (ZFPs) for therapeutic g...he nomination of Thomas G.,Wiggans to the company,...served as Chief Executive Officer of,Connetics Cor...as Chairman,of the Board from January 2006, until ...
... prepares for commercial launch of first ...28 AssureRx, a personalized medicine,company, ann...e president,of sales and marketing. He will be res...tial launch strategy, building the sales force, an...ny,s first product. Lucas is an,experienced pharma...
Other Biology Technology:MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008 2Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 2Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 3Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors 4AssureRx Adds VP of Sales and Marketing 2
(Date:12/2/2009)... student at the University of Southampton,s School... Oceanography Centre, Southampton (NOCS) has forma...rom the deep sea. , Hall discovered the new spec... Museum of Natural History in Washington. Explaini...rabs include some of the largest crustaceans curre...
(Date:12/1/2009)...nts have two different feeding strategies. A larg...ning that they are generalist predators feeding on...s. Some, however, are "herbivorous". This is not...k of their diets consist of plant-derived matter. ... by plants to attract ants, called extra-floral ne...
(Date:12/1/2009)...ptiNose is pleased to announce the publication of ...ting the efficacy and tolerability of its novel, i...tment of chronic rhinosinusitis with nasal polyps ...ational and European Rhinologic Societies. , Ch...c disease that can significantly reduce a patient,...
Breaking Biology News(10 mins):King crab family bigger than ever 2Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Spectral appoints new board member 13559 1Spectral appoints new board member 13559 2New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 1New Mexico School Boards Association and Accelify Announce Alliance to Assist New Mexico Schools 54497 2Dr Robert Lanza is Featured Guest on Deepak Chopras SIRIUS XM Stars Radio Show 13558 1Dr Robert Lanza is Featured Guest on Deepak Chopras SIRIUS XM Stars Radio Show 13558 2Dr Robert Lanza is Featured Guest on Deepak Chopras SIRIUS XM Stars Radio Show 13558 3
... issue of Restoration Ecology finds that in coasta...Oyster reefs are self-sustaining, and are addition... have the potential for long-term growth, and cont... , Oyster larvae move in groups and water-borne ch...re therefore able to maintain themselves as new re...
...nternational consortium of scientists, including a...e for Molecular Bioscience (IMB), will transform o...e a complex organism like a human being. , The fi...mic Sciences Center, RIKEN Yokohama Institute and ..., will be published today in two papers in the pre...
...anksgiving dinner table might consider giving than...uice, say dental researchers who have discovered t...ing cavities. , A team led by oral biologist Hyun... Rochester Medical Center has discovered that the ...eapon against bladder infections also hold promise...
Other Biology News:New insights into the software of life 2Give thanks for the cranberry, say dental researchers 2Give thanks for the cranberry, say dental researchers 3
GC-RICH PCR System from Roche Applied Science
GC-RICH PCR System from Roche Applied Science
BD Laminin 60 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 60 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: